Efficacy and Safety of Fecal Microbiota Transplantation

  • End date
    Dec 31, 2026
  • participants needed
  • sponsor
    Guangzhou First People's Hospital
Updated on 19 April 2021


In recent years, researches illustrate that multifactorial diseases such as functional gastrointestinal disorders, autoimmune diseases, metabolic, behavioral and neurological diseases are associated with an abnormal microbiome structure-dysbiosis, which means the imbalance of the microbiome community. Fecal microbiota transplantation (FMT), the infusion of faeces from a healthy donor to the gastrointestinal tract of a recipient patient aiming to alter the intestine microbiota, is recommended to be performed in Clostridium difficile infection(CDI) as the most effective therapy. It also being used experimentally in the treatment of the disease states linked to dysbiosis of the intestinal microbiota. However, the efficacy and safety of FMT to treat the dysbiosis-associated diseases is still in its infancy. To further verify the indications above, more data is required to be collected through studies.

Condition Fecal Microbiota Transplantation
Treatment Fecal Microbiota Transplantation
Clinical Study IdentifierNCT04706611
SponsorGuangzhou First People's Hospital
Last Modified on19 April 2021


Yes No Not Sure

Inclusion Criteria

Confirmed diagnosis of any of following diseases
Irritable Bowel Syndrome
Ulcerative colitis
Crohn's disease
Clostridium Difficile Infection
Functional Dyspepsia
Parkinson's Disease
Metabolic Syndrome
Non-Alcoholic Fatty Liver Disease
Autism Spectrum Disorder
Radiation Enteritis
Atopic Dermatitis
Food Allergic
Graft-versus-Host Disease
Diabetes mellitus
Multi-Drug Resistant Infection
Hepatic Encephalopathy
Enteric Dysbacteriosis
Multiple Sclerosis
Pseudomembranous Enteritis
Acute Pancreatitis
Chronic Fatigue Syndrome
Acute-on-chronic Liver Failure with HBV Infection
Alcoholic Liver Disease
Decompensated Cirrhosis
Henoch-Schonlein Purpura
Autoimmune Liver Disease
Systemic Lupus Erythematosus
Rheumatoid arthritis
IgG4-Related Disease
Celiac Disease
Protein-losing Enteropathy
Asperger Syndrome
Rheumatoid arthritis
Ankylosing spondylitis
Immune checkpoint inhibition-related colitis
Autoimmune enteropathy
Drug-induced diarrhea
Suffering from gastrointestinal symptoms such as constipation, diarrheas, abdominal pain, flatulence, etc
The participants must be able to tolerate the FMT infusion method such as endoscopy, colonoscopy, capsule, nasoduodenal tube insertion, etc

Exclusion Criteria

Current pregnancy or breast-feeding
Suffering from other severe diseases, including liver or kidney failure, heart failure, MODS, coma, cerebrovascular accident
Known contraindication to all FMT infusion method such as nasoduodenal tube insertion, endoscopy, colonoscopy and enema
Any conditions that may render the efficacy of FMT or at the discretion of the investigators
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note